carbamates has been researched along with Libman-Sacks Disease in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We conducted an observational prospective study, on 232 patients with chronic kidney disease, undergoing treatment with paritaprevir/ombitasvir/ritonavir and dasabuvir, for chronic hepatitis C infection - genotype 1b." | 3.96 | Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease. ( Iliescu, EL; Mercan-Stanciu, A; Toma, L, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iliescu, EL | 1 |
| Mercan-Stanciu, A | 1 |
| Toma, L | 1 |
| Ceccarelli, F | 1 |
| Perricone, C | 1 |
| Colasanti, T | 1 |
| Massaro, L | 1 |
| Cipriano, E | 1 |
| Pendolino, M | 1 |
| Natalucci, F | 1 |
| Mancini, R | 1 |
| Spinelli, FR | 1 |
| Valesini, G | 1 |
| Conti, F | 1 |
| Alessandri, C | 1 |
2 other studies available for carbamates and Libman-Sacks Disease
| Article | Year |
|---|---|
Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Cryoglobulinemia; Cyclopropanes; Drug Thera | 2020 |
Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus.
Topics: Anti-Citrullinated Protein Antibodies; Autoantibodies; Biomarkers; Carbamates; Cohort Studies; Cross | 2018 |